1 completed, 1 recruiting. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Recruiting 1 |
Follow Transplantation: new trials by email Literature Review of Transplantation trials Research Report on Transplantation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Early Efficacy of iPSC-Derived Motor Neuron Progenitor Cells (XS228) in Subacute Spinal Cord Injury: A Phase I Trial Allogeneic Human Induced Pluripotent Stem Cell (iPSC)-Derived Motor Neuron Progenitor Cells - Spinal Cord Injury, Safety | Phase 1 | Recruiting | XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd. | 12 | 2025-07-02 | 2025-11-25 |
| Subcutaneous Pharmacokinetics of Belatacept belatacept, Placebo - Transplantation | Phase 1 | Completed | Bristol-Myers Squibb | 153 | 2007-12-01 | 2016-09-22 |
Central Nervous System Diseases (1) · Nervous System Diseases (1) · Spinal Cord Diseases (1) · Trauma, Nervous System (1) · Wounds and Injuries (1)
Abatacept (1)
Bristol-Myers Squibb (1) · XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd. (1)
China (1) · United States (1)